• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

EXCLUSIVE: ‘The Man She Is Today’: European Companies Accused Of ‘Importing’ Woke Ideology

May 29, 2025

‘The Economy Is On Fire!’: Kevin O’Leary Drops Fact Check On CNN Panelists Railing Against Trump’s Economy

May 29, 2025

DeSantis Signs Bill Making Gold And Silver Legal Tender

May 28, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Saturday, May 31
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    EXCLUSIVE: ‘The Man She Is Today’: European Companies Accused Of ‘Importing’ Woke Ideology

    May 29, 2025

    ‘The Economy Is On Fire!’: Kevin O’Leary Drops Fact Check On CNN Panelists Railing Against Trump’s Economy

    May 29, 2025

    DeSantis Signs Bill Making Gold And Silver Legal Tender

    May 28, 2025

    John Deere Announces $20 Billion Plan To Build Up American Manufacturing

    May 28, 2025

    EV Startup Promised To Cut China Ties — Then Reportedly Shared US Data Anyway

    May 27, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Finance»Eli Lilly Stock Hits Record High As Diabetes Powerhouse Stokes Beat And Raise
Finance

Eli Lilly Stock Hits Record High As Diabetes Powerhouse Stokes Beat And Raise

August 8, 2023No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Eli Lilly Stock Hits Record High As Diabetes Powerhouse Stokes Beat And Raise
Share
Facebook Twitter LinkedIn Pinterest Email

Eli Lilly (LLY) stock broke out bullishly Tuesday after the drugmaker walloped Wall Street’s second-quarter forecasts partly due to diabetes treatment powerhouse Mounjaro.




X



Mounjaro sales skyrocketed by a quadruple-digit percentage, bringing in $979.7 million. That topped expectations by more than $200 million, Leerink Partners analyst David Risinger said in a note to clients. Third Bridge analyst Lee Brown says experts are “excited about Mounjaro.” Lilly is now hoping the Food and Drug Administration will approve it for weight loss.

If that happens, Mounjaro will directly rival Novo Nordisk‘s (NVO) Wegovy, the only approved drug in the GLP-1 class for obesity treatment. On Tuesday, Novo said a five-year study showed Wegovy reduced the risk of cardiovascular events. That includes heart attacks and strokes in overweight adults or those with obesity and cardiovascular disease, but not diabetes.

“This is good news for Eli Lilly, which is awaiting FDA approval for a weight-loss (use) in diabetes drug, Mounjaro,” Edward Jones analyst John Boylan said in his note to clients. “Insurance plans still need to agree to reimburse for these drugs for certain patient types, but (Novo’s study) results should open the door for this possibility.”

Eli Lilly stock catapulted 17.1%, near 531.90, in morning trading on today’s stock market. Novo shares rocketed 16.3% near 187.60. Both stocks broke out of flat bases. Eli Lilly stock topped a buy point at 469.87, according to MarketSmith.com. Novo’s entry was at 172.97.

Eli Lilly Stock: Lilly Easily Beats Forecasts

Overall, Lilly earned an adjusted $2.11 per share on $8.31 billion in second-quarter sales. The two metrics easily topped Eli Lilly stock analyst forecasts for a respective $1.98 per share and $7.58 billion, according to FactSet.

See also  Why wealthy customers are the 'most worrisome' for banks right now

Lilly’s earnings soared almost 69%, though it benefited from a payment of 43 cents related to the sale of its hypoglycemia drug to Amphastar Pharmaceuticals (AMPH), Third Bridge’s Brown said in a note. Sales advanced 28%.

In addition to strong Mounjaro sales, Eli Lilly noted strength from cancer drug Verzenio. It also highlighted strength in diabetes treatment Jardiance and autoimmune drug Taltz. Sales of all three beat projections, Leerink’s Risinger said in a note. Verzenio sales surged 57% to $926.8 million. Jardiance and Taltz revenue advanced 45% and 16%, respectively, to $668.3 million and $703.9 million.

Edward Jones’ Boylan noted Eli Lilly is making progress in diabetes, obesity and Alzheimer’s. The company expects regulators in the U.S. and Europe to make approval decisions on experimental Alzheimer’s treatment before the year’s end.

“But we believe our strong growth expectations are not reflected in the price of the shares,” he said.

Lilly also raised its outlook for the year. It now expects to earn an adjusted $9.70 to $9.90 a share on $33.4 billion to $33.9 billion revenue. Eli Lilly stock analysts had called for earnings of $8.73 per share on $31.44 billion in sales.

Weight-Loss Drugs In Focus

Importantly, Novo’s news could help make the case for broader insurance coverage of GLP-1 drugs Wegovy and Mounjaro. These drugs mimic a gut hormone tied to feelings of satiety and how quickly the stomach empties itself. They can also improve markers of type 2 diabetes.

Mounjaro isn’t yet approved in obesity treatment, though Lilly hopes to win that nod this year. Novo, on the other hand, sells its drug semaglutide as a weight-loss medicine called Wegovy. It also sells it as diabetes drugs Ozempic and Rybelsus.

See also  Dow Jones Futures Rise On Cool CPI Inflation Data; Cathie Wood Sells $92 Million Of Tesla Stock

In Novo’s study, patients without diabetes but established cardiovascular disease experienced a 20% reduction in the risk of heart attack, stroke or cardiovascular-related death over five years. Lilly is also running a study showing Mounjaro can improve morbidity and mortality. Those results are expected in October 2027, Leerink’s Risinger said.

“The results (from Novo) beat our expectations and provide a perception positive for Lilly and the GLP-1 class in terms of payer coverage,” he said.

He has an outperform rating on Eli Lilly stock.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Here’s Why Embattled Apellis Stock, A Former Highflier, Just Took Another Hit To The Chin

Why Sage Lost Half Its Value After The FDA Approved Its Depression Drug

IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks

Want More IBD Insights? Subscribe To Our Investing Podcast!

See Stocks On The List Of Leaders Near A Buy Point

Beat diabetes Eli high hits Lilly Powerhouse raise record stock Stokes
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

110 Short Graduation Quotes for High School Seniors and University Graduates in 2025

May 5, 2025

‘Exactly What We Want To See’: US Job Growth Beat Expectations For Second Month In A Row

May 2, 2025

$15 Billion And Climbing: Trump’s Tariffs Deliver Record High Revenue

April 25, 2025

Ending China’s De Minimis Exception Brings 3 Benefits for Americans

April 17, 2025
Add A Comment

Leave A Reply Cancel Reply

Top Posts

We’re Not Incentivizing Iran to Take Hostages with Deal, Iran Already Sees Value in Taking Hostages

August 15, 2023

How To Read a Sunscreen Bottle, According to Dermatologists

April 28, 2023

Private equity giant KKR’s antidote to worker discontent — employee stock ownership programs

July 29, 2023

Cheap Stocks To Buy: 5 Growth Stocks To Watch Right Now

March 22, 2023
Don't Miss

EXCLUSIVE: ‘The Man She Is Today’: European Companies Accused Of ‘Importing’ Woke Ideology

Business May 29, 2025

Consumers’ Research issued a “Woke Alert” on Thursday warning American shoppers that three European companies…

‘The Economy Is On Fire!’: Kevin O’Leary Drops Fact Check On CNN Panelists Railing Against Trump’s Economy

May 29, 2025

DeSantis Signs Bill Making Gold And Silver Legal Tender

May 28, 2025

John Deere Announces $20 Billion Plan To Build Up American Manufacturing

May 28, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,136)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,645)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

Drake Concertgoer Speaks Out After Being Identified as Bra Thrower

July 25, 2023

Democrats Are Getting Tough On No Labels

July 17, 2023

China’s Floundering Economy Triggers Plunge in Global Stocks and Oil Prices

June 24, 2023
Popular Posts

EXCLUSIVE: ‘The Man She Is Today’: European Companies Accused Of ‘Importing’ Woke Ideology

May 29, 2025

‘The Economy Is On Fire!’: Kevin O’Leary Drops Fact Check On CNN Panelists Railing Against Trump’s Economy

May 29, 2025

DeSantis Signs Bill Making Gold And Silver Legal Tender

May 28, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.